Amgen Inc. (NASDAQ:AMGN) is included among the 15 Best S&P 500 Dividend Stocks to Buy in 2026. On January 20, Bernstein ...

If you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want ...

Amgen Inc. Buy thesis: strong pipeline, 12% Q3 2025 revenue growth and MariTide obesity upside. Click for this updated look ...

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Wall Street’s top analyst upgrades/downgrades from earnings season: Amgen, Chevron, P&G, Netflix, Applied Materials, Datadog ...

Amgen Inc (AMGN) reached a significant milestone as its stock hit a 52-week high of $346.41. This marks a notable point for the biotechnology company, reflecting a positive trend over the past year.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

According to Benzinga Pro, Amgen Inc's peer group average for short interest as a percentage of float is 7.24%, which means ...

Amgen (AMGN) ended the recent trading session at $347.07, demonstrating a +1.01% change from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily gain of 0.55%.

In addition to DBS, Amgen also received a Buy from Piper Sandler’s David Amsellem in a report issued on January 20. However, on the same day, Bernstein downgraded Amgen (NASDAQ: AMGN) to a Hold.